Jan 12, 2023 / 05:45PM GMT
Noah I. Eisenberg - JPMorgan Chase & Co, Research Division - Research Analyst
Okay. With that, I guess we'll get started. Good morning, everyone. My name is Noah Eisenberg. I'm a biotech research associated with JPMorgan. It is my pleasure to introduce our next company -- presenting company, Autolus. Presenting on behalf of the company is CEO, Christian Itin. After the presentation, there will be a Q&A session. (Operator Instructions). So with that, I'll hand it over to Christian.
Christian Martin Itin - Autolus Therapeutics plc - CEO & Director
Thank you very much, and welcome, everybody. And first off, congratulations. You made it to Thursday at the JPMorgan conference. So that's an accomplishment in its own right. So great to see you all. And frankly, thanks for joining this late presentation and the schedule.
I'll be introducing you and walking you through where we are and where we stand with the -- our programs. We're developing CAR T therapies. And obviously, we're a listed company, and please look at our SEC filings for the risk
Autolus Therapeutics PLC at JPMorgan Healthcare Conference Transcript
Jan 12, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers